http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112716979-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-84 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-90 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0605 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 |
| filingDate | 2021-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112716979-B |
| titleOfInvention | Pharmaceutical use of amniotic epithelial cell conditioned medium |
| abstract | The present invention provides the pharmaceutical use of amniotic epithelial cell conditioned medium eye drops, the application of an amniotic epithelial cell conditioned medium in the preparation of eye drops, and the application of the amniotic epithelial cell conditioned medium in the preparation of medicines for allergic conjunctivitis. Application, and a preparation method of amniotic epithelial cell conditioned medium eye drops. The pharmaceutical application of the amniotic epithelial cell conditioned medium eye drops of the present invention is the first discovery and proof that the conditioned medium derived from human amniotic epithelial cells can inhibit allergic conjunctivitis. Using the amniotic epithelial cell conditioned medium eye drops of the present invention to treat conjunctivitis and allergic conjunctivitis has low immunogenicity, avoids direct use of cells, is safe and effective, and has high product stability. |
| priorityDate | 2021-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 68.